RE: Big pharma investing: cancer drugs26 Jun 2018 11:50
Yes- I think their techniques are so expensive because they're more invasive and time consuming for patients and doctors. OXB are in this field too- massively expensive and maybe always will be- you can't exactly mass produce and it's a difficult process. They take cells from the patient and assess their specific immunity- extracting cells, re-formulating them and re-inserting them with additional stimulus to immune cells- highly individualised. Amazing though hey? I think VAL has a higher response rate too so far. VAL won't have to sell at such a high price- one of the great things about their drugs- effective and affordable.